Literature DB >> 25567262

Rave drug tested against depression.

Sara Reardon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25567262     DOI： 10.1038/517130a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  4 in total

Review 1.  Ketamine use in current clinical practice.

Authors:  Mei Gao; Damoon Rejaei; Hong Liu
Journal:  Acta Pharmacol Sin       Date:  2016-03-28       Impact factor: 6.150

2.  Editorial (Thematic Selection: Inflammatory and Immune Responses in Depression).

Authors:  Abhay Sharma
Journal:  Curr Neuropharmacol       Date:  2016       Impact factor: 7.363

3.  Comeback of ketamine: resurfacing facts and dispelling myths.

Authors:  Abhijit Kumar; Amit Kohli
Journal:  Korean J Anesthesiol       Date:  2021-01-11

4.  Ketamine Modulates Zic5 Expression via the Notch Signaling Pathway in Neural Crest Induction.

Authors:  Yu Shi; Jiejing Li; Chunjiang Chen; Yongwu Xia; Yanxi Li; Pan Zhang; Ying Xu; Tingyu Li; Weihui Zhou; Weihong Song
Journal:  Front Mol Neurosci       Date:  2018-02-07       Impact factor: 5.639
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.